Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management

Chimeric antigen receptor T-cells (CAR-T) are improving outcomes in pediatric and adult patients with relapsed or refractory B-cell acute lymphoblastic leukemias and subtypes of non-Hodgkin Lymphoma. As this treatment is being increasingly utilized, a better understanding of the unique toxicities as...

Descripción completa

Detalles Bibliográficos
Autores principales: Burns, Ethan A., Gentille, Cesar, Trachtenberg, Barry, Pingali, Sai Ravi, Anand, Kartik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006027/
https://www.ncbi.nlm.nih.gov/pubmed/33802788
http://dx.doi.org/10.3390/diseases9010020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006027/
https://www.ncbi.nlm.nih.gov/pubmed/33802788
http://dx.doi.org/10.3390/diseases9010020

Ejemplares similares